MAM
McLean Asset Management’s Elevance Health ELV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $259K | Sell |
740
-699
| -49% | -$245K | 0.07% | 141 |
|
2025
Q1 | $620K | Buy |
1,439
+32
| +2% | +$13.8K | 0.2% | 63 |
|
2024
Q4 | $519K | Sell |
1,407
-131
| -9% | -$48.3K | 0.16% | 75 |
|
2024
Q3 | $757K | Sell |
1,538
-8
| -0.5% | -$3.94K | 0.23% | 58 |
|
2024
Q2 | $826K | Sell |
1,546
-99
| -6% | -$52.9K | 0.27% | 49 |
|
2024
Q1 | $846K | Sell |
1,645
-35
| -2% | -$18K | 0.29% | 46 |
|
2023
Q4 | $806K | Buy |
1,680
+1
| +0.1% | +$480 | 0.3% | 45 |
|
2023
Q3 | $764K | Sell |
1,679
-9
| -0.5% | -$4.1K | 0.31% | 46 |
|
2023
Q2 | $750K | Hold |
1,688
| – | – | 0.29% | 45 |
|
2023
Q1 | $776K | Sell |
1,688
-29
| -2% | -$13.3K | 0.32% | 44 |
|
2022
Q4 | $881K | Buy |
1,717
+14
| +0.8% | +$7.18K | 0.3% | 45 |
|
2022
Q3 | $795K | Buy |
1,703
+1
| +0.1% | +$467 | 0.31% | 39 |
|
2022
Q2 | $824K | Buy |
1,702
+3
| +0.2% | +$1.45K | 0.33% | 34 |
|
2022
Q1 | $834K | Buy |
1,699
+16
| +1% | +$7.85K | 0.62% | 32 |
|
2021
Q4 | $760K | Sell |
1,683
-14
| -0.8% | -$6.32K | 0.29% | 39 |
|
2021
Q3 | $740K | Buy |
1,697
+127
| +8% | +$55.4K | 0.28% | 42 |
|
2021
Q2 | $618K | Buy |
1,570
+10
| +0.6% | +$3.94K | 0.28% | 41 |
|
2021
Q1 | $588K | Buy |
1,560
+16
| +1% | +$6.03K | 0.46% | 38 |
|
2020
Q4 | $496K | Buy |
+1,544
| New | +$496K | 0.44% | 36 |
|